glp 1 for nash Full article: GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients Why are GLP-1 agonists being
Description
ACS Mater Au
Diabetes Care, 41(3), S232-S245
those regimens require clinical dose adjustment and monitoring
GLP1 has other actions, including the inhibition of glucagon secretion, appetite and gastric motility
[DOI] [PubMed] [Google Scholar] 23.Liu X, Zhang Y, Zheng SY, Lin R, Xie YJ, Chen H, et al
A GLP-1 friendly label is good in theory, but its bulls***
